These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Antibodies neutralizing hepsin protease activity do not impact cell growth but inhibit invasion of prostate and ovarian tumor cells in culture. Xuan JA; Schneider D; Toy P; Lin R; Newton A; Zhu Y; Finster S; Vogel D; Mintzer B; Dinter H; Light D; Parry R; Polokoff M; Whitlow M; Wu Q; Parry G Cancer Res; 2006 Apr; 66(7):3611-9. PubMed ID: 16585186 [TBL] [Abstract][Full Text] [Related]
5. Pericellular activation of hepatocyte growth factor by the transmembrane serine proteases matriptase and hepsin, but not by the membrane-associated protease uPA. Owen KA; Qiu D; Alves J; Schumacher AM; Kilpatrick LM; Li J; Harris JL; Ellis V Biochem J; 2010 Feb; 426(2):219-28. PubMed ID: 20015050 [TBL] [Abstract][Full Text] [Related]
6. The role of type II transmembrane serine protease-mediated signaling in cancer. Tanabe LM; List K FEBS J; 2017 May; 284(10):1421-1436. PubMed ID: 27870503 [TBL] [Abstract][Full Text] [Related]
7. Hepsin promotes prostate cancer progression and metastasis. Klezovitch O; Chevillet J; Mirosevich J; Roberts RL; Matusik RJ; Vasioukhin V Cancer Cell; 2004 Aug; 6(2):185-95. PubMed ID: 15324701 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of basement membrane formation by a nidogen-binding laminin gamma1-chain fragment in human skin-organotypic cocultures. Breitkreutz D; Mirancea N; Schmidt C; Beck R; Werner U; Stark HJ; Gerl M; Fusenig NE J Cell Sci; 2004 May; 117(Pt 12):2611-22. PubMed ID: 15159456 [TBL] [Abstract][Full Text] [Related]
9. Laminin-332 is a substrate for hepsin, a protease associated with prostate cancer progression. Tripathi M; Nandana S; Yamashita H; Ganesan R; Kirchhofer D; Quaranta V J Biol Chem; 2008 Nov; 283(45):30576-84. PubMed ID: 18784072 [TBL] [Abstract][Full Text] [Related]
11. Collagen-IV and laminin-1 regulate estrogen receptor alpha expression and function in mouse mammary epithelial cells. Novaro V; Roskelley CD; Bissell MJ J Cell Sci; 2003 Jul; 116(Pt 14):2975-86. PubMed ID: 12808020 [TBL] [Abstract][Full Text] [Related]
12. Discovery of Selective Matriptase and Hepsin Serine Protease Inhibitors: Useful Chemical Tools for Cancer Cell Biology. Damalanka VC; Han Z; Karmakar P; O'Donoghue AJ; La Greca F; Kim T; Pant SM; Helander J; Klefström J; Craik CS; Janetka JW J Med Chem; 2019 Jan; 62(2):480-490. PubMed ID: 30571119 [TBL] [Abstract][Full Text] [Related]
13. Hepatocyte growth factor activator inhibitor-1 (HAI-1) is essential for the integrity of basement membranes in the developing placental labyrinth. Fan B; Brennan J; Grant D; Peale F; Rangell L; Kirchhofer D Dev Biol; 2007 Mar; 303(1):222-30. PubMed ID: 17174946 [TBL] [Abstract][Full Text] [Related]
14. Pericellular regulation of prostate cancer expressed kallikrein-related peptidases and matrix metalloproteinases by cell surface serine proteases. Reid JC; Matsika A; Davies CM; He Y; Broomfield A; Bennett NC; Magdolen V; Srinivasan B; Clements JA; Hooper JD Am J Cancer Res; 2017; 7(11):2257-2274. PubMed ID: 29218249 [TBL] [Abstract][Full Text] [Related]
15. Hepsin, a cell surface serine protease identified in hepatoma cells, is overexpressed in ovarian cancer. Tanimoto H; Yan Y; Clarke J; Korourian S; Shigemasa K; Parmley TH; Parham GP; O'Brien TJ Cancer Res; 1997 Jul; 57(14):2884-7. PubMed ID: 9230195 [TBL] [Abstract][Full Text] [Related]
16. Using 3D Culture of Primary Mammary Epithelial Cells to Define Molecular Entities Required for Acinus Formation: Analyzing MAP Kinase Phosphatases. Gajewska M; McNally S Methods Mol Biol; 2017; 1501():199-216. PubMed ID: 27796954 [TBL] [Abstract][Full Text] [Related]
17. Hepsin: a multifunctional transmembrane serine protease in pathobiology. Li S; Wang L; Sun S; Wu Q FEBS J; 2021 Sep; 288(18):5252-5264. PubMed ID: 33300264 [TBL] [Abstract][Full Text] [Related]
18. Advancing science and technology via 3D culture on basement membrane matrix. Benton G; George J; Kleinman HK; Arnaoutova IP J Cell Physiol; 2009 Oct; 221(1):18-25. PubMed ID: 19492404 [TBL] [Abstract][Full Text] [Related]
19. Recent Advances of Hepsin-Targeted Inhibitors. Kwon H; Han J; Lee KY; Son SH; Byun Y Curr Med Chem; 2017; 24(21):2294-2311. PubMed ID: 28245763 [TBL] [Abstract][Full Text] [Related]
20. Clinical Significance of Hepsin and Underlying Signaling Pathways in Prostate Cancer. Lu L; Cole A; Huang D; Wang Q; Guo Z; Yang W; Lu J Biomolecules; 2022 Jan; 12(2):. PubMed ID: 35204704 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]